227 related articles for article (PubMed ID: 32876207)
1. Evaluation of a rapid serological test for detection of IgM and igG antibodies against SARS-CoV-2 under field conditions.
Vidal-Anzardo M; Solis G; Solari L; Minaya G; Ayala-Quintanilla B; Astete-Cornejo J; Luque-Aguilar A; Jorge A; Rojas N; Cardenas F; Soto A
Rev Peru Med Exp Salud Publica; 2020; 37(2):203-209. PubMed ID: 32876207
[TBL] [Abstract][Full Text] [Related]
2. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
[TBL] [Abstract][Full Text] [Related]
3. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
4. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
[No Abstract] [Full Text] [Related]
5. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
[TBL] [Abstract][Full Text] [Related]
6. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
[TBL] [Abstract][Full Text] [Related]
7. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ
J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737
[TBL] [Abstract][Full Text] [Related]
8. Rapid Detection of COVID-19 by Serological Methods and the Evaluation of Diagnostic Efficacy of IgM and IgG.
Huang S; Lin C; Yan M; Li H; Liu T; Michael W; Xiang J; Shen C
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180423
[TBL] [Abstract][Full Text] [Related]
9. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
[TBL] [Abstract][Full Text] [Related]
10. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era.
Arpino G; De Angelis C; De Placido P; Pietroluongo E; Formisano L; Bianco R; Fiore G; Montella E; Forestieri V; Lauria R; Cardalesi C; Vozzella EA; Iervolino A; Giuliano M; De Placido S
ESMO Open; 2020 Sep; 5(5):e000885. PubMed ID: 32958531
[TBL] [Abstract][Full Text] [Related]
11. The Light and Shadow of Rapid Serological Tests for SARS-CoV-2 Infection: Results from a Study in a Large Emergency Department.
Loconsole D; Centrone F; Morcavallo C; Campanella S; Sallustio A; Quarto M; Procacci V; Chironna M
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32906596
[TBL] [Abstract][Full Text] [Related]
12. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
13. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.
Pérez-García F; Pérez-Tanoira R; Romanyk J; Arroyo T; Gómez-Herruz P; Cuadros-González J
J Clin Virol; 2020 Aug; 129():104473. PubMed ID: 32504945
[TBL] [Abstract][Full Text] [Related]
14. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
[TBL] [Abstract][Full Text] [Related]
15. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
[TBL] [Abstract][Full Text] [Related]
16. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.
Risch M; Weber M; Thiel S; Grossmann K; Wohlwend N; Lung T; Hillmann D; Ritzler M; Ferrara F; Bigler S; Egli K; Bodmer T; Imperiali M; Salimi Y; Fleisch F; Cusini A; Renz H; Kohler P; Vernazza P; Kahlert CR; Paprotny M; Risch L
Biomed Res Int; 2020; 2020():9878453. PubMed ID: 33224987
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans.
Martinaud C; Hejl C; Igert A; Bigaillon C; Bonnet C; Mérens A; Wolf A; Foissaud V; Leparc-Goffart I
J Clin Virol; 2020 Sep; 130():104571. PubMed ID: 32750664
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different serological assays for SARS-CoV-2 in real life.
Brochot E; Demey B; Handala L; François C; Duverlie G; Castelain S
J Clin Virol; 2020 Sep; 130():104569. PubMed ID: 32769023
[TBL] [Abstract][Full Text] [Related]
19. Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients.
Wechselberger C; Süßner S; Doppler S; Bernhard D
J Clin Virol; 2020 Oct; 131():104589. PubMed ID: 32810840
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]